Compugen | CGEN - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Arca Biopharma USD 2.23M 1.08M 2025-12
aTyr Pharma USD 700.63K 81.56M 2026-03
Bio Path USD 199K 300K 2025-09
Brainstorm Cell Therapeutics USD 1.39M 326K 2025-12
Cara Therapeutics USD 2.19M 2.45M 2025-09
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.43M 222K 2026-03
Immunic USD 3.45M 451K 2025-12
Minerva Neurosciences USD 2.48M 58.79K 2024-09
RedHill Biopharma USD 4.48M 1.52M 2024-03
TherapeuticsMD USD 1.23M 90K 2024-06